Drug
HRS-4729 clinical trials
- studies test it
- 5
- open now
- 4
- in phase 3
- 0
- first study started
- 2025
Keep track of what changes. Save the HRS-4729 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
5 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HRS-4729 is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study of HRS-4729 Injection in Participants With Type 2 DiabetesNot yet recruitingPhase 2Fujian Shengdi Pharmaceutical Co., Ltd.NCT07843862Written as HRS-4729 Injection
- A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentRecruitingPhase 1Fujian Shengdi Pharmaceutical Co., Ltd.NCT07807059Written as HRS-4729
- A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated SteatohepatitisRecruitingPhase 2Fujian Shengdi Pharmaceutical Co., Ltd.NCT07660848Written as HRS-4729 Injection
- A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in ObesityNot yet recruitingPhase 2Fujian Shengdi Pharmaceutical Co., Ltd.NCT07690826Written as HRS-4729 Injection
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy SubjectsCompletedPhase 1Fujian Shengdi Pharmaceutical Co., Ltd.NCT06762600Written as HRS-4729 injection